MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
22.90
-0.79
-3.33%
After Hours: 22.90 0 0.00% 16:11 07/11 EDT
OPEN
23.68
PREV CLOSE
23.69
HIGH
23.91
LOW
22.75
VOLUME
504.33K
TURNOVER
--
52 WEEK HIGH
27.64
52 WEEK LOW
11.16
MARKET CAP
1.06B
P/E (TTM)
-10.0872
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-U.S. STOCKS ON THE MOVE-Huntington Ingalls, Nucor, Estee Lauder
Reuters · 3d ago
Pacira announces layoffs due to efficiencies in Exparel production
Seeking Alpha · 3d ago
BUZZ-Pacira BioSciences falls after co cuts jobs amid manufacturing upgrade
Reuters · 3d ago
Pacira BioSciences to Close Manufacturing Suite, Lay Off 71 Employees
Dow Jones · 3d ago
Pacira Pharmaceuticals Implements Workforce Reduction for Efficiency
TipRanks · 3d ago
PACIRA BIOSCIENCES INC - ESTIMATES $2.4-$2.8 MLN PRE-TAX CHARGES FOR TERMINATION - SEC FILING
Reuters · 3d ago
PACIRA BIOSCIENCES INC - ANNOUNCES WORKFORCE REDUCTION IN SAN DIEGO - SEC FILING
Reuters · 3d ago
Pacira Biosciences Inc. Announces Reorganization, Shuts Down 45-Liter Facility, Reduces Workforce by 70
Reuters · 3d ago
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.